WallachBeth Capital Announces Pricing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering
Summary
The closing of the offering is expected to occur on or about January 31, 2024, subject to the satisfaction of customary closing conditions.The underwriters have been granted an option, exercisable within 45 days after the closing of this offering, to purchase shares of 60Ps common stock at a price of $0.385 per share and/or Warrants at a price of $0.01 per Warrant and/or Pre-Funded Warrants at a price of $0.375 per Pre-Funded Warrant, or any combination of additional shares of common stock, Warrants and/or Pre-Funded Warrants, representing, in the aggregate, up to 15% of the number of Units sold in this offering, 15% of the Warrants underlying the Units and Pre-Funded Units sold in this offering and 15% of the Pre-Funded Warrants underlying the Pre-Funded Units sold in this offering, in all cases less the underwriting discount to cover over-allotments, if any.WallachBeth Capital is the Sole Bookrunner for the OfferingThe offering is being conducted pursuant to 60Ps registration statement on Form S1 (File No. The firms website is located at .This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.This press release may include forward-looking statements, including statements of future expectations regarding the business and offering of 60Ps units. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions. Readers of this press release are cautioned not to place undue reliance on any forward-looking statements. We undertake no obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws.